JAN 15, 2015
Humana Implements Step Therapy Policy for Retinal Treatments
By Chantay Moye
The Academy is objecting to a troublesome decision by Humana that places new limitations or requires utilization management of certain drugs under its new commercial formularies for 2015. As part of its step therapy policy that began Jan. 1, the health insurance giant requires the use of Avastin before patients can use Eylea or Lucentis for all commercial plans.